Clinigen Group PLC operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Clinigen Group PLC with three other
drug stores in Europe:
EQL Pharma AB
sales of 72.03 million Swedish Kronor [US$8.48 million]
Udg Healthcare Plc
(1.14 billion Euros [US$1.36 billion]
McKesson Europe AG
based in GERMANY
(17.12 billion Euros [US$20.48 billion]
of which 77%
was Pharmaceutical distributions).
During the year ended June of 2020, sales at
Clinigen Group PLC were £504.30 million (US$671.51 million).
increase of 10.4%
versus 2019, when the company's sales were £456.90 million.
This was the third consecutive year of growth at Clinigen Group PLC.
Sales of Commercial Medicines saw an increase
that was more than double the company's growth rate: sales were up
42.1% in 2020, from
£110.30 million to £156.70 million.
Not all segments of Clinigen Group PLC experienced an increase in sales in 2020:
sales of Unlicensed Medicines fell 4.3% to £197.00 million.